- Home
- ACET vs MIND Comparison
ACET vs MIND Comparison
Compare ACET & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- MIND
- Stock Information
- Founded
- ACET 1947
- MIND 1987
- Country
- ACET United States
- MIND United States
- Employees
- ACET N/A
- MIND N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- MIND Industrial Machinery/Components
- Sector
- ACET Health Care
- MIND Industrials
- Exchange
- ACET Nasdaq
- MIND Nasdaq
- Market Cap
- ACET 70.3M
- MIND 57.3M
- IPO Year
- ACET N/A
- MIND 1994
- Fundamental
- Price
- ACET $0.72
- MIND $5.82
- Analyst Decision
- ACET Buy
- MIND
- Analyst Count
- ACET 6
- MIND 0
- Target Price
- ACET $6.00
- MIND N/A
- AVG Volume (30 Days)
- ACET 324.2K
- MIND 174.1K
- Earning Date
- ACET 03-06-2025
- MIND 04-28-2025
- Dividend Yield
- ACET N/A
- MIND N/A
- EPS Growth
- ACET N/A
- MIND N/A
- EPS
- ACET N/A
- MIND 6.61
- Revenue
- ACET N/A
- MIND $45,197,000.00
- Revenue This Year
- ACET N/A
- MIND $22.98
- Revenue Next Year
- ACET N/A
- MIND $10.18
- P/E Ratio
- ACET N/A
- MIND $0.88
- Revenue Growth
- ACET N/A
- MIND 41.23
- 52 Week Low
- ACET $0.69
- MIND $3.05
- 52 Week High
- ACET $2.40
- MIND $11.10
- Technical
- Relative Strength Index (RSI)
- ACET 37.26
- MIND 30.96
- Support Level
- ACET $0.74
- MIND $5.59
- Resistance Level
- ACET $0.91
- MIND $7.23
- Average True Range (ATR)
- ACET 0.06
- MIND 0.49
- MACD
- ACET -0.00
- MIND -0.07
- Stochastic Oscillator
- ACET 12.61
- MIND 10.41
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.